REGENXBIO, Inc. (RGNX)
8.06
-2.66
(-24.81%)
USD |
NASDAQ |
Aug 24, 16:00
8.08
+0.02
(+0.25%)
After-Hours: 20:00
REGENXBIO Total Liabilities (Quarterly) : 314.85M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 314.85M |
| March 31, 2026 | 320.81M |
| December 31, 2025 | 350.30M |
| September 30, 2025 | 363.75M |
| June 30, 2025 | 367.35M |
| March 31, 2025 | 216.73M |
| December 31, 2024 | 206.34M |
| September 30, 2024 | 217.70M |
| June 30, 2024 | 221.11M |
| March 31, 2024 | 238.55M |
| December 31, 2023 | 262.23M |
| September 30, 2023 | 270.69M |
| June 30, 2023 | 276.60M |
| March 31, 2023 | 282.69M |
| December 31, 2022 | 317.07M |
| September 30, 2022 | 319.97M |
| June 30, 2022 | 322.92M |
| March 31, 2022 | 335.70M |
| December 31, 2021 | 349.61M |
| September 30, 2021 | 338.98M |
| June 30, 2021 | 329.16M |
| March 31, 2021 | 324.94M |
| December 31, 2020 | 330.41M |
| Date | Value |
|---|---|
| September 30, 2020 | 125.51M |
| June 30, 2020 | 51.88M |
| March 31, 2020 | 43.78M |
| December 31, 2019 | 47.71M |
| September 30, 2019 | 40.84M |
| June 30, 2019 | 34.55M |
| March 31, 2019 | 31.98M |
| December 31, 2018 | 34.97M |
| September 30, 2018 | 20.93M |
| June 30, 2018 | 18.76M |
| March 31, 2018 | 17.88M |
| December 31, 2017 | 15.65M |
| September 30, 2017 | 14.60M |
| June 30, 2017 | 12.68M |
| March 31, 2017 | 11.23M |
| December 31, 2016 | 11.00M |
| September 30, 2016 | 15.75M |
| June 30, 2016 | 9.897M |
| March 31, 2016 | 6.383M |
| December 31, 2015 | 4.572M |
| September 30, 2015 | 5.506M |
| June 30, 2015 | 6.172M |
| March 31, 2015 | 7.134M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | 141.00B |
| Capricor Therapeutics, Inc. | 122.52M |
| Biogen, Inc. | 13.24B |
| Ardelyx, Inc. | 426.88M |
| Ocugen, Inc. | 140.76M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 386.62M |
| Shareholders Equity (Quarterly) | 71.76M |
| Debt to Equity Ratio | 3.49 |
| Current Ratio | 2.858 |
| Net Debt Paydown Yield | -3.60% |